from the total FPI outflow, 2,24,790 crore has been withdrawn from equity Market – about 95% of the total outflow. Meanwhile, FPIs almost sold out 15,749 crore in debt instruments. On the other hand, they were net buyers in the debt-VRR and hybrid market, with an influx of 2,065 crore and 1,802 crores respectively so far this year.
Let’s take a look at five stocks that got the love from FPIs in the April-June quarter:
Max Healthcare Institute:
Shares of Max Healthcare closed on BSE On Friday, 367.05 each fell 1.71%. Its market cap is approx. 35,590.43 crores.
Shares of Max Healthcare have gained nearly 5 per cent during the April-June 2022 period. However, in one year, so far, the shares have gained about 38%. stock was around 266 level a year ago on July 15.
As per the latest shareholding pattern, the holding of FPIs in the company is around 22,63,17,204 equity shares or 23.34 per cent.
According to Trendline data, this is an increase of 8.75% from the shareholding position as of March 2022, where FPIs held 14.59% stake in the company.
Max Healthcare is one of the largest healthcare organizations in India, operating 17 healthcare facilities (3400+ beds) across NCR Delhi, Haryana, Punjab, Uttarakhand and Maharashtra. About 85% of our bed capacity is in Metro/Tier 1 cities. Apart from hospitals, Max Healthcare also operates a homecare business and pathology business under the brand names Max@Home and Max Labs respectively.
As on March 31, 2022, the revenue of the company was 5,218 crore, an increase of 44%, while the PAT is on 837 crore as compared to a net loss of 95 crore in FY21. Network operating EBITDA more than doubled during the fiscal year and was 1,390 crores. This includes the EBITDA of 85 crore from COVID-19 vaccination and related antibody tests. Operating margin for FY22 was 26.6%, a sharp improvement from 17.5% in FY21.
GHCL:
GHCL shares closed on BSE above 644.20 each 4.80 or 0.75%. Its market cap is approx. 6,157.64 crores.
In the period April to June 2022, the shares of GHCL have gained over 11%. But the shares have gained at least 108.34 per cent in one year. shares were around 309 level on 15 July last year.
As per the latest shareholding pattern, the FPI portfolio increased to 1,76,83,367 equity shares or 18.50% of the company. Data from Trendline shows that this was a 3.08% increase from the 15.42% holding in the March 2022 quarter.
GHCL was incorporated in October 1983 and since then, it has established itself as a diversified conglomerate with a market capitalization of approx. 3,000 crores. It has traced its footprints in the chemicals, textiles and consumer products segments.
In FY22, the revenue of the company was 3,778.36 crore up from 2,491.18 crore in the last financial year. PAT arrived almost double as compared to 546.70 crores 326.12 crore in the financial year 2011.
Varun Beverages:
Shares of Varun Beverages closed on BSE below 826.60 10.90 or 1.03%. Its market cap at present is approx. 53,691.77 crore.
Varun Beverages has gained over 31 per cent in the April-June quarter. Whereas the shares have gained about 56 per cent in one year. Shares were around on July 15 last year 530 level on BSE.
As per the shareholding filing, FPI holding in Varun Beverages has reached 15,54,67,761 equity shares or 23.93% as on June 2022 quarter. Data from Trendline shows that holdings have increased by 2.90% from 21.03% in the March quarter.
Varun Beverages is the second largest franchisee in the world (outside the US) of carbonated soft drinks (“CSD”) and non-carbonated beverages (“NCBs”) sold under the trademarks owned by PepsiCo. The company produces and distributes a wide range of CSDs, as well as a large selection of NCBs including packaged drinking water. PepsiCo CSD brands we produce and sell include Pepsi, Diet Pepsi, 7UP, Mirinda Orange, Mirinda Lemon, Mountain Dew, 7UP Lemon Masala Soda, 7UP Revive, Everwess Soda. The PepsiCo NCB brands we produce and sell include Tropicana Slice, Tropicana Frutz (Lychee, Apple and Mango), 7UP Lime as well as packaged drinking water under the Aquafina brand.
the company’s revenue is 2,269.88 crore in FY22 as compared to Rs. 8,958.29 crore in FY21. its PAT around 136.75 Cr Vs 746.05 crore in FY21.
Last month, Varun Beverages had issued a bonus issue of equity shares in the ratio of 1:2. ICICI Direct’s Research Analyst Sanjay Manyal said after the bonus issue, ‘Our target price has been revised. 867 per share. We maintain our BUY rating on the stock.”
The key triggers for the stock as per the analyst are – 1) With dynamics normalizing, South and West regions are likely to witness strong volume growth following a strong summer season following acquisitions, 2) The company has seen several new brand launches have done. Last two years i.e. string, ‘mountain dew ICE’, a milk based drink. The new products are contributing ~10% to the volumes and are likely to support revenue going forward, and 3) Given the need for capex equivalent to depreciation, VBL will fully rebalance its balance sheet over the next three to four years. Will be able to de-leverage. Strong free cash flow. The reduction in interest cost is expected to boost profits.
Gujarat State Fertilizers and Chemicals:
On BSE, shares of GSFC closed on 138.85 up 1.95 or 1.42%. Its market cap is approx. 5,532.86 crore.
Shares of GSFC have lost at least 20.25% in the April-June quarter this year. However, in the year the company’s shares were up around . has climbed more than 21% compared to The level of 114 on 15 July last year.
As per the shareholding pattern, the holding of FPIs in GSFC increased to 10,51,28,734 equity shares or 26.38%. Data from Trendline showed that holdings grew by 2.59% from 26.38% in the March quarter.
In FY22, the company’s consolidated revenue from operations was 9,082.64 crore vs. 7,634.06 crore in FY21. Consolidated PAT arrived 898.58 crore as compared to 450.11 crore in FY 2011.
GSFC is a state-owned company for the manufacture of plastics, nylons, fibres, industrial gases and various chemicals and fertilizer products including urea, ammonia, ammonium sulfate, sulfuric acid, phosphoric acid and diammonium phosphate, caprolactam, melamine, methanol.
Tata Alexi:
Shares of Tata Group backed company closed on BSE more than 8055.85 each 257.85 or 3.31%. The market cap of the company is 50,168.97 crores at present.
Shares fell nearly 10% during the April-June quarter due to the bearish tone of the market. However, over the year, the shares have gained over 79.5% 4,487 level on 15 July 2022.
As per the shareholding pattern, the FPI’s holding in the company stood at 94,46,929 equity shares or 15.17%. Trendline data shows it grew 2.02% from 13.15% in the March quarter.
Tata Elxsi has declared the first quarter results for FY23. In the June 2022 quarter, the company posted a net profit of 184.7 crores grew 62.9% year-on-year and 15.4% quarter-on-quarter. Growth was primarily volume-based, with strong growth of 6.2%, 6.6% and 19.8% QoQ across all three segments of EPD, IDV and SIS.
respectively. Revenue 6.5% qoq and 30% yoy to . climbed 725.9 crores. EBITDA grew by 7.6% yoy and 58.8% qoq 238.2 crores. The company also crossed 10,000 workforce in Q1 with 771 net additions in the quarter.
Tata Alexi is one of the world’s leading providers of design and technology services across industries including Automotive, Broadcast, Communications, Healthcare and Transportation.
Disclaimer: The views and recommendations given above are those of individual analysts or broking companies and not of Mint.
catch all business News, market news, today’s fresh news events and breaking news Updates on Live Mint. download mint news app To get daily market updates.